abstract |
The present invention relates to novel pyrrolopyridinyloxyphenylamide derivatives, or a pharmaceutically acceptable salt thereof; A composition for inhibiting c-MET activity comprising the same as an active ingredient, and a pharmaceutical composition for preventing or treating hyperproliferative disorder. |